U.S. task force: End routine prostate cancer screening

NEW YORK (Reuters) - A task force advising the U.S. government on Monday recommended against routine use of the prostate-cancer screening test called PSA, or prostate specific antigen, for lack of a discernible health benefit. Like a draft proposal last October, the U.S. Preventive Services Task Force gave PSA screening a D, for "don't recommend" in healthy men. The reaction was fast and furious ...

Scientists discover distinct molecular subtype of prostate cancer

( New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College ) A collaborative expedition into the deep genetics of prostate cancer has uncovered a distinct subtype of the disease, one that appears to account for up to 15 percent of all cases, say researchers at Weill Cornell Medical College, the Broad Institute of MIT and Harvard and the Dana-Farber Cancer ...